Clin2
NCT07074444Likely a fitRecruiting

Treating clonorchiasis with three different drugs

Clonorchiasis

Treatments studied

Part of Infections clinical trials.

This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
318 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with clonorchiasis (a liver fluke infection) through a stool or bile test.
  • You are not allergic to albendazole, praziquantel, or tribendimidine.
  • You do not have certain heart rhythm problems (supraventricular tachycardia or atrial fibrillation).
  • You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use effective birth control during the study and for 3 months after treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06376396Not yet recruiting· Phase 4
Two medicines vs one for brain parasite infection

This trial tests whether a combination of two medicines (praziquantel and albendazole) works better than one medicine (albendazole alone) for treating a parasitic brain infection that causes seizures. Participants will be hospitalized for up to 20 days and followed for one year to see how well the infection clears and if symptoms improve.

NCT06367361Not yet recruiting· Phase 2
Comparing oxfendazole with triclabendazole for chronic liver fluke

This study tests whether one or two doses of oxfendazole (a newer drug) works as well as the standard two-dose triclabendazole treatment for chronic fascioliasis (liver fluke infection). It may offer a simpler treatment option.

NCT04713787Recruiting· Phase 2
Test higher doses of oxfendazole against single-dose albendazole

This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.

Santa Clara, Maynas
NCT07262814Recruiting· Phase 2
Testing arpraziquantel for liver fluke in children

This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.

Vientiane
NCT07754617Not yet recruiting· Phase 2/Phase 3
Comparing treatment schedules for liver scarring from schistosomiasis

This trial tests two different schedules of the drug praziquantel to see which works better for treating liver scarring caused by a parasitic infection called schistosomiasis. It aims to improve liver health and prevent complications.

Entebbe
NCT06252961Recruiting· Phase 2/Phase 3
Testing levamisole for loiasis infection

This trial tests if a medicine called levamisole can safely reduce the number of loiasis (eye worm) parasites in your blood. You would take the medicine for 3 to 5 days and be monitored.

Sibiti, Komono

Hear when a new Clonorchiasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.